Redsense Medical Balance Sheet Health
Financial Health criteria checks 6/6
Redsense Medical has a total shareholder equity of SEK39.6M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK41.8M and SEK2.2M respectively. Redsense Medical's EBIT is SEK209.0K making its interest coverage ratio -1.6. It has cash and short-term investments of SEK15.4M.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | -1.6x |
| Cash | SEK 15.36m |
| Equity | SEK 39.59m |
| Total liabilities | SEK 2.21m |
| Total assets | SEK 41.80m |
Recent financial health updates
Here's Why We're Watching Redsense Medical's (NGM:REDS) Cash Burn Situation
Jun 15
Redsense Medical (NGM:REDS) Is In A Good Position To Deliver On Growth Plans
Mar 01We're Not Very Worried About Redsense Medical's (NGM:REDS) Cash Burn Rate
Nov 10Is Redsense Medical (NGM:REDS) In A Good Position To Deliver On Growth Plans?
Apr 20Recent updates
Here's Why We're Watching Redsense Medical's (NGM:REDS) Cash Burn Situation
Jun 15Redsense Medical (NGM:REDS) Is In A Good Position To Deliver On Growth Plans
Mar 01We're Not Very Worried About Redsense Medical's (NGM:REDS) Cash Burn Rate
Nov 10Is Redsense Medical (NGM:REDS) In A Good Position To Deliver On Growth Plans?
Apr 20Shareholders Are Thrilled That The Redsense Medical (NGM:REDS) Share Price Increased 236%
Feb 24Financial Position Analysis
Short Term Liabilities: REDS's short term assets (SEK28.0M) exceed its short term liabilities (SEK2.2M).
Long Term Liabilities: REDS has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: REDS is debt free.
Reducing Debt: REDS has no debt compared to 5 years ago when its debt to equity ratio was 8.6%.
Debt Coverage: REDS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: REDS has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/07 08:44 |
| End of Day Share Price | 2025/05/05 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Redsense Medical AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Maria Karlsson Osipova | Penser Access |